MCM
TLSI icon

MAI Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

MAI Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60 Buy
+15
New +$73 ﹤0.01% 4841

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

MAI Capital Management's TLSI Position: Q1 2026 in Review

MAI Capital Management opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 15 shares worth $60. The stake represents ﹤0.01% of the portfolio and ranks #4841 among its holdings.

84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • MAI Capital Management held 15 shares of TriSalus Life Sciences worth $60 as of Q1 2026.
  • TriSalus Life Sciences was a new MAI Capital Management position in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4841 holding.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.